Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000218154 | SCV000270613 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Tyr163Tyr in Exon 06 of NEBL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence. It has been identified in 1/3738 African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs141153708). |
Gene |
RCV000218154 | SCV000527767 | likely benign | not specified | 2016-05-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000470967 | SCV000563548 | likely benign | Primary dilated cardiomyopathy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003929896 | SCV004741152 | likely benign | NEBL-related disorder | 2019-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |